Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
pre nda meeting fda guidance | 1.83 | 0.7 | 3612 | 49 |
pre anda meeting fda guidance | 1.66 | 0.1 | 8046 | 56 |
fda nda guidance 2019 | 1.27 | 0.9 | 2089 | 64 |
fda nda guidance 2016 | 0.84 | 0.5 | 6742 | 60 |
fda guidance for nda | 1.53 | 1 | 6843 | 71 |
fda nda guidance 2017 | 1.9 | 0.9 | 2663 | 87 |
fda nda guidance 2014 | 1.41 | 0.3 | 1470 | 89 |
fda nda guidance 2015 | 0.99 | 0.3 | 483 | 34 |
fda guidance on nda submission | 0.33 | 0.2 | 3967 | 12 |
fda nda guidance 2018 | 1.82 | 0.2 | 6343 | 9 |
fda pre ind meeting guidance | 1.7 | 0.2 | 1506 | 39 |
fda nda guidance 2010 | 0.03 | 0.9 | 2292 | 65 |
fda pre sub meeting guidance | 0.05 | 0.4 | 365 | 68 |
pre-nda meeting | 0.4 | 0.4 | 4895 | 68 |
fda nda guidance 2012 | 1.89 | 1 | 6204 | 73 |
fda guidance content of nda | 1.59 | 0.5 | 663 | 97 |
fda nda guidance 2013 | 0.69 | 0.1 | 290 | 10 |
pre nda meeting timeline | 0.7 | 0.6 | 3807 | 4 |
fda guidelines for nda submission | 1.6 | 0.3 | 1058 | 40 |
fda nda guidance 2009 | 1.74 | 0.4 | 3250 | 35 |
pre-ind meeting fda guidance | 0.44 | 0.5 | 6839 | 99 |
fda nda guidance 2011 | 0.26 | 0.7 | 6546 | 50 |
nda submission to fda | 0.57 | 1 | 9729 | 65 |
nda submitted to fda | 0.35 | 0.2 | 5662 | 15 |
fda review timelines for nda | 1.18 | 0.8 | 2562 | 67 |